Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
Rising to the Challenge of Developing Novel Orphan Medicines for the Global Market
Track : Track 17: Rare/Orphan Diseases
Program Code: 360
Date: Wednesday, June 26, 2013
Time: 1:45 PM to 3:15 PM  EST
Location: 205B
CHAIR :
 Cecil J. Nick, MS (SCHNON), FTOPRA, Vice President (Technical), PAREXEL Consulting, United Kingdom
SPEAKER (S):
Audrey Gordon, JD (SPKSUP), President, Executive Director, Progeria Research Foundation, United States
John Ziegler, MD (SPKNON), Medical Director, Premier Research Group, United States
Gayatri R. Rao, JD,MD (SPKAGY), Acting Director, Office of Orphan Products Development, Ofc of the Commissioner, FDA, United States
 Spiros Vamvakas, MD (SPKAGY), Head of Scientific Advice, Human Medicines Special Areas, European Medicines Agency, European Union, United Kingdom
Description
One in ten people could be affected by a rare disease; for many there is no treatment, yet modern technology could resolve this. This session investigates the opportunities available to facilitate successful global development of novel orphan medicines.

Session Recording
(Code: 360)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON4 Comp Access: Wednesday Online Access Package - June 26, 2013
Handout Online
(Code: 360)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON4 Comp Access: Wednesday Online Access Package - June 26, 2013
Rising to the Challenge of Developing Novel Orphan Medicines for the Global Market